Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI.

Details

Language :

English

Volume :

3

Database :

Complementary Index

Journal :

Antimicrobial Stewardship & Healthcare Epidemiology

Publication Type :

Academic Journal

Accession number :

178619945

Full Text :

https://doi.org/10.1017/ash.2023.281